Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models

Chrysovalantou Mihailidou, Pavlos Papakotoulas, Athanasios G. Papavassiliou, Michalis V. Karamouzis

DOI: 10.18632/oncotarget.23164
Published: 2017-12-08
Container: Oncotarget
Publisher: Impact Journals, LLC
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.23164,
  title = {Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models},
  author = {Chrysovalantou Mihailidou and Pavlos Papakotoulas and Athanasios G. Papavassiliou and Michalis V. Karamouzis},
  year = {2017},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.23164},
  url = {https://doi.org/10.18632/oncotarget.23164}
}

RIS

TY  - JOUR
TI  - Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models
AU  - Chrysovalantou Mihailidou
AU  - Pavlos Papakotoulas
AU  - Athanasios G. Papavassiliou
AU  - Michalis V. Karamouzis
PY  - 2017
JO  - Oncotarget
DO  - 10.18632/oncotarget.23164
UR  - https://doi.org/10.18632/oncotarget.23164
ER  -

APA

Mihailidou, C., Papakotoulas, P., Papavassiliou, A. G., & Karamouzis, M. V. (2017). Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Oncotarget. https://doi.org/10.18632/oncotarget.23164

Source records

crossref · retrieved 2026-09-25T02:30:45.320Z